QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
LON:BTG

BTG (BTG) Share Price, News & Analysis

GBX 840
+1.00 (+0.12%)
(As of 08/19/2019)
Today's Range
840
840
50-Day Range
840
840
52-Week Range
512.50
853
Volume
271,742 shs
Average Volume
960,389 shs
Market Capitalization
£3.26 billion
P/E Ratio
29.47
Dividend Yield
N/A
Price Target
N/A
BTG stock logo

About BTG Stock (LON:BTG)

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

BTG Stock Price History

BTG Stock News Headlines

Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
BTG Jul 2024 1.000 call
BTG Jul 2024 2.000 put
Auna Announces Launch of Initial Public Offering
PagBank just upgraded at BTG Pactual, here's why
BTG Jan 2025 1.500 put
BTG Apr 2024 1.000 call
Q4 2023 Nu Holdings Ltd Earnings Call
Bytes CEO resigns amid share trading storm
Royal Gold: A Solid Buy The Dip Candidate
Betagro PCL BTG
Q4 2023 Vinci Partners Investments Ltd Earnings Call
See More Headlines
Receive BTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2018
Today
3/28/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,631
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£914.10 million
Cash Flow
GBX 90.80 per share
Book Value
GBX 355.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.26 billion
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Louise Makin MA (Age 58)
    Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director
  • Mr. Duncan Kennedy A.C.A.
    B.Sc., CFO & Director
  • Dr. Peter Stratford (Age 52)
    Chief Technical Officer & Head of Innovation
  • Mr. Andy Burrows
    VP of Corp. & Investor Relations
  • Dr. Paul Mussenden
    Gen. Counsel, Head of Strategic Affairs & Company Sec.

BTG Stock Analysis - Frequently Asked Questions

How have BTG shares performed in 2024?

BTG's stock was trading at GBX 840 on January 1st, 2024. Since then, BTG shares have increased by 0.0% and is now trading at GBX 840.
View the best growth stocks for 2024 here
.

How were BTG's earnings last quarter?

BTG plc (LON:BTG) posted its quarterly earnings data on Tuesday, May, 15th. The company reported $32.90 EPS for the quarter, topping the consensus estimate of $29.80 by $3.10.

What other stocks do shareholders of BTG own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Vectura Group (VEC), Bank of America (BAC), B2Gold (BTO), Serco Group (SRP), Tahoe Resources (TAHO) and Advanced Micro Devices (AMD).

How do I buy shares of BTG?

Shares of BTG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:BTG) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners